Lack of aspirin-induced decrease in thrombin formation in subjects resistant to aspirin [5]

Thrombosis and Haemostasis

Volumn 97, Issue 6, 2007, Pages 1056-1058

  Undas, Anetta ^a   Placzkiewicz Jankowska, Ewa ^a   Zieliński, Lukasz ^b   Tracz, Wieslawa ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; NITRIC ACID DERIVATIVE; THROMBIN;

ADULT; BLEEDING TIME; BLOOD ANALYSIS; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LETTER; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENT DISEASE; REFERENCE VALUE; SIDE EFFECT; THROMBOCYTE AGGREGATION; THROMBOSIS; TREATMENT DURATION; UNSTABLE ANGINA PECTORIS;

ASPIRIN; BLEEDING TIME; BLOOD PLATELETS; CARDIOVASCULAR DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; PEPTIDE FRAGMENTS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PROTHROMBIN; RISK FACTORS; THROMBIN; THROMBOXANE B2;

EID: 34250645339     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-01-0047     Document Type: Letter

References (15)

1. Undas A, Brummel-Ziedins KE, Mann KG. Anti-thrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions. Blood 2007; 109:285-22.
2. Kyrle PA, Westwick J, Scully MF, et al. Investigation of the interaction of blood platelets with the coagulation system at the site of plug formation ex vivo in man: effect of low-dose aspirin. Thromb Haemost 1987;57:62-69.
3. Undas A, Brummel K, Musial J, et al. Blood coagulation at the site of microvascular injury: effects of lowdose aspirin. Blood 2001; 98: 2423-2431.
4. Szczeklik A, Musial J, Undas A, et al. Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia. J Am Coll Cardiol 1999; 33: 1286-1293.
5. Musial J, Undas A, Undas R, et al. Treatment with simvastatin and low-dose aspirin depresses thrombin generation in patients with coronary heart disease and borderline-high cholesterol levels. Thromb Haemost 2001;85:221-225.
6. Hankey GJ, Eikelboom JW. Aspirin resistance. Lancet 2006; 367: 606-617.
7. McKee SA, Sane Dc, Deliargyris EN. Aspirin resistance in cardiovascular disease: a review of prevalence, mechanisms, and clinical significance. Thromb Haemost 2002; 88: 711-715.
8. Tantry US, Blinden KP, Gurbel PA. Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation. J Am Coll Cardiol 2005; 46: 1705-1709.
9. Undas A, Brummel KE, Musial J, et al. Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation. Circulation 2001; 103: 2248-2253.
10. Undas A, Undas R, Musial J, et al. A low dose of aspirin (75 mg/day) lowers thrombin generation to a similar extent as a high dose of aspirin (300 mg/day). Blood Coagul Fibrinolysis 2000; 11: 231-234.
11. Szczeklik A, Musial J, Undas A, et al. Inhibition of thrombin generation by aspirin is blunted in hypercholesterolemia. Arterioscler Thromb Vasc Biol 1996; 16: 948-954.
12. Friend M, Vucenik I, Miller M. Platelet responsiveness to aspirin in patients with hyperlipidaemia. Br Med J 2003; 326: 82-83.
13. Williams PC, Coffey MJ, Coles B, et al. In vivo aspirin supplementation inhibits nitric oxide consumption by human platelets. Blood 2005; 106: 2737-2743.
14. Undas A, Celinska-Lowenhoff M, Kaczor M, et al. New nonlipid effects of statins and their clinical relevance in cardiovascular disease. Thromb Haemost 2004;91:1065-1077.
15. Patrono C, Rocca B. Drug insight: aspirin resistance - fact or fashion? Nat Clin Pract Cardiovasc Med 2007;4:42-70.